Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
13F holders, Q2 2021
Institutional positions in Adma Biologics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- −14 vs. Q1 2021
- Shares held
- 42.9M
- −5.65M (−11.6%) vs. Q1 2021
- Total value
- $68.6M
- −$16.8M (−19.7%) vs. Q1 2021
- New holders
- 17
- 20 more added
- Sold out
- 31
- 35 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $1.70B |
| Q1 2026 | 358 | $1.91B |
| Q4 2025 | 357 | $4.02B |
| Q3 2025 | 366 | $3.28B |
| Q2 2025 | 369 | $3.84B |
| Q1 2025 | 347 | $4.07B |
| Q4 2024 | 321 | $3.50B |
| Q3 2024 | 306 | $4.16B |
| Q2 2024 | 253 | $2.03B |
| Q1 2024 | 214 | $1.16B |
| Q4 2023 | 184 | $764.6M |
| Q3 2023 | 188 | $612.7M |
| Q2 2023 | 179 | $610.6M |
| Q1 2023 | 163 | $547.2M |
| Q4 2022 | 160 | $592.2M |
| Q3 2022 | 130 | $315.4M |
| Q2 2022 | 113 | $236.0M |
| Q1 2022 | 105 | $189.9M |
| Q4 2021 | 88 | $137.1M |
| Q3 2021 | 72 | $47.3M |
| Q2 2021 | 90 | $68.6M |
| Q1 2021 | 104 | $85.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Adma Biologics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −38,346−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −37,525−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −34,170−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −31,982−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −29,751−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −29,207−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −19,873−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −18,968−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −18,328−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −17,896−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −17,612−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −12,909−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −12,360−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −7,063−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −4,185−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,009−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,397−100.0% | Sold out |
| Certified Advisory Corp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −400−100.0% | Sold out |